Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
Panin Bank Center 9th Floor,Jl. Jend. Sudirman,Senayan
Jakarta; Jakarta; Map
Postal Code: 10270
Tel: +62-21-7278-,+62-21-7278-
Fax: +62-21-722-
Email: @mpi-pharmaniaga.co.id

Full name: Pt Millennium Pharmacon International Tbk

Previous name(s): ()

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1611434
ISIN: ID1000072804
Incorporation Date: 1952

Main Activities

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers

Main Products

Pharmaceuticals, nutritional and consumer goods.

Company Description

PT. Millennium Pharmacon International Tbk. (SDPC), operates in activities relating to distribution of pharmaceuticals, nutritional and consumer goods. SDPC also provides medical supplies (prescription and non-prescription) and medical equipment to government institutions. SDPC was listed on Indonesia Stock Exchange in 1990 under the Development Board. The company was founded in 1952 and based in Jakarta, Indonesia.

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 133.00
Volume 247,700
Turnover 32,820,250
Index Jakarta Composite Index
Market Indonesia Stock Exchange
Ticker SDPC
Market Cap Market Cap 97,552,000
52 Week High 149.00
52 Week Low 75.00
Price to Earnings (P/E) 8.78
Earnings per Share (EPS) 15.26
Dividend Yield
Bookvalue 437,598,463
Enterprise Value 360,185,438
Quote updated on April 21, 2017
Note: data in IDR Thousands.

Key Executives

President

Ownership Details

Pharmaniaga Int. Corp. Sdn Bhd
55%
Other

Key Stats

Select Items to chart them. 2016 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 733,443,472
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.

Financials

Competitors - Indonesia

IDR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest